The assessment of chromosomal abnormalities is a key component in the evaluation of blood cancers and is typically performed by karyotyping and fluorescence in situ hybridization (FISH). These cytogenetic techniques only analyze small numbers of cells (20 – 200) and are not “tumor-specific.” Hence, they are unsuitable for precise detection of genomic aberrations, low-level clones, or disease monitoring. In this webinar, we will describe a new innovative approach we developed that resolves these limitations. The method called “Immuno-flowFISH”: immunophenotyping, flow cytometry, and FISH uses the Cytek Amnis ImageStreamX Mk II imaging flow cytometer for analysis. This integrated multi-parametric flow cytometric immunophenotyping and FISH method is performed on cells in suspension with one experiment and does not require any prior cell isolation or cell separation.
Key topics discussed in this webinar will include:
.Applications of imaging flow cytometry for FISH analysis and immunophenotyping of cells
.Technical aspects for immuno-flowFISH protocol development and optimization
.Clinical examples across a range of hematological malignancies
Who should attend:
.Imaging flow cytometry users looking to improve their data quality and analysis
.Researchers in immunology, oncology, genomics, and measurable residual disease
.Anyone interested in flow cytometry or imaging flow cytometry
Kathy Fuller, Associate Professor of Translational Oncology, University of Western Australia
June 12, 2024 | 3:30pm PDT | 6:30pm EDT
Register here